435 related articles for article (PubMed ID: 27676224)
1. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
[TBL] [Abstract][Full Text] [Related]
2. Kinetic characterization and allosteric inhibition of the Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase).
Haymond A; Johny C; Dowdy T; Schweibenz B; Villarroel K; Young R; Mantooth CJ; Patel T; Bases J; San Jose G; Jackson ER; Dowd CS; Couch RD
PLoS One; 2014; 9(8):e106243. PubMed ID: 25171339
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
[TBL] [Abstract][Full Text] [Related]
5. The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
Jackson ER; San Jose G; Brothers RC; Edelstein EK; Sheldon Z; Haymond A; Johny C; Boshoff HI; Couch RD; Dowd CS
Bioorg Med Chem Lett; 2014 Jan; 24(2):649-53. PubMed ID: 24360562
[TBL] [Abstract][Full Text] [Related]
6. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
Singh N; Chevé G; Avery MA; McCurdy CR
Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD).
Haymond A; Dowdy T; Johny C; Johnson C; Ball H; Dailey A; Schweibenz B; Villarroel K; Young R; Mantooth CJ; Patel T; Bases J; Dowd CS; Couch RD
Anal Biochem; 2018 Feb; 542():63-75. PubMed ID: 29180070
[TBL] [Abstract][Full Text] [Related]
8. Design of Potential Bisubstrate Inhibitors against
San Jose G; Jackson ER; Uh E; Johny C; Haymond A; Lundberg L; Pinkham C; Kehn-Hall K; Boshoff HI; Couch RD; Dowd CS
Medchemcomm; 2013 Jul; 4(7):1099-1104. PubMed ID: 23914289
[TBL] [Abstract][Full Text] [Related]
9. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
[TBL] [Abstract][Full Text] [Related]
10. Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.
Kesharwani S; Sundriyal S
Eur J Med Chem; 2021 Mar; 213():113055. PubMed ID: 33303239
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
Jackson ER; Dowd CS
Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial mechanism of epigallocatechin gallate and gallocatechin gallate: They target 1-deoxy-d-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
Hui X; Hua SH; Wu QQ; Li H; Gao WY
Arch Biochem Biophys; 2017 May; 622():1-8. PubMed ID: 28428039
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.
McKenney ES; Sargent M; Khan H; Uh E; Jackson ER; San Jose G; Couch RD; Dowd CS; van Hoek ML
PLoS One; 2012; 7(10):e38167. PubMed ID: 23077474
[TBL] [Abstract][Full Text] [Related]
17. Reverse
Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of green tea and the catechins against 1-deoxy-d-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
Hui X; Liu H; Tian FL; Li FF; Li H; Gao WY
Fitoterapia; 2016 Sep; 113():80-4. PubMed ID: 27439219
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Murkin AS; Manning KA; Kholodar SA
Bioorg Chem; 2014 Dec; 57():171-185. PubMed ID: 24998420
[TBL] [Abstract][Full Text] [Related]
20. The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis.
Wang X; Dowd CS
ACS Infect Dis; 2018 Mar; 4(3):278-290. PubMed ID: 29390176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
